Outcome, Severity, and Risk of Mortality in Patients With Covid-19 and Chronic Underlying Diseases: A Prospective Study Publisher



Salimi A^{1, 2} ; Aghaziarati M¹ ; Balalami MQR¹ ; Rastgoo N¹ ; Taghizadeh F¹ ; Pirastepoor Z¹ ; Aghchekand ZB¹ ; Boroujeny ZA¹ ; Akhavizadegan H³ Show Affiliations
Source: Archives of Clinical Infectious Diseases Published:2021

Abstract

Background: The novel coronavirus pandemic, severe acute respiratory syndrome CoV-2 (SARS COV-2), has become a global threat and rapidly spread worldwide. The COVID-19 pandemic has posed a number of challenges, the most notable of which is the management of patients with chronic underlying diseases. Objectives: The present study aimed to evaluate the risk of COVID-19 severity and mortality in patients with chronic underlying diseases. Methods: In this retrospective cohort study, the data on the disease severity and morality of confirmed COVID-19 patients admit-ted to Baharloo Hospital, Tehran, Iran, from February 2020 to March 2020 were analyzed and reported. Patients’ characteristics, including age, gender, and underlying diseases, were also considered. Results: The study encompassed 1244 patients with the mean age of 53.29 years, among whom there were 573 patients with at least one co-existing chronic disease. Hypertension, diabetes mellitus (DM), and ischemic heart disease (IHD) were the most common co-existing chronic diseases. The findings revealed that underlying diseases were significantly associated with disease mortality and severity. Conclusions: The findings showed that patients with comorbidities were significantly at higher risk of death and severe forms of COVID-19. In this regard, patients with underlying diseases should be of concern. © 2022, Author(s).